Back to Search Start Over

Acute hemodynamic effects of tolvaptan, a vasopressin v(2) receptor blocker, in patients with symptomatic heart failure and systolic dysfunction an international, multicenter, randomized, placebo-controlled trial.

Authors :
Udelson JE
Orlandi C
Ouyang J
Krasa H
Zimmer CA
Frivold G
Haught WH
Meymandi S
Macarie C
Raef D
Wedge P
Konstam MA
Gheorghiade M
Source :
Journal of the American College of Cardiology (JACC). Nov2008, Vol. 52 Issue 19, p1540-1545. 6p.
Publication Year :
2008

Details

Language :
English
ISSN :
07351097
Volume :
52
Issue :
19
Database :
Academic Search Index
Journal :
Journal of the American College of Cardiology (JACC)
Publication Type :
Academic Journal
Accession number :
105571439
Full Text :
https://doi.org/10.1016/j.jacc.2008.08.013